obesity drug news today glp-1 today october 2025 GLP-1 trends 2025: real-world data, patient outcomes & future therapies Why GLP-1 drugs are changing

These datasets include: in vivo data for the mouse studies and encompass metabolic, biochemical and histological data/images

Here's a quick overview: Quick comparison Note: Side effects like nausea or digestive issues are common but often temporary

There is limited peer-reviewed evidence specifically studying GLP-1 microdosing for weight management

[DOI] [PubMed] [Google Scholar] 145.Navaneethan S.D., Bansal N., Cavanaugh K.L., Chang A., Crowley S., Delgado C., Estrella M.M., Ghossein C., Ikizler T.A., Koncicki H., et al

This update follows reports of adverse effects such as nausea, vomiting, and abdominal pain among users

Furthermore, the discovery of miRNAs as modulators of GLP-1 signaling opens exciting avenues for future research